MRI may let thousands of breast cancer patients ditch radiation

NCT ID NCT06445738

Recruiting now Disease control Sponsor: Breast Cancer Trials, Australia and New Zealand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special MRI scan before surgery can identify women with early breast cancer who have a very low risk of the cancer coming back. If so, they may be able to skip radiotherapy after surgery, avoiding its side effects. The trial will follow 1,400 women aged 50 and older for up to 10 years to see how often the cancer returns in the same breast.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER FEMALE

Contacts and locations

Locations

Baylor St Luke's Medical Centre
NOT_YET_RECRUITING

Houston, Texas, 77030, United States
Lake Macquarie Private Hospital
NOT_YET_RECRUITING

Gateshead, New South Wales, 2290, Australia
Mater Hospital, Sydney
RECRUITING

North Sydney, New South Wales, 2060, Australia
Monash Cancer Centre (MMC Moorabbin)
RECRUITING

Clayton, Victoria, 3168, Australia
Royal Adelaide Hospital
NOT_YET_RECRUITING

Adelaide, South Australia, 5000, Australia
The Chris O'Brien Lifehouse
NOT_YET_RECRUITING

Camperdown, New South Wales, 2050, Australia
The Royal Melbourne Hospital
RECRUITING

Melbourne, Victoria, 3000, Australia
UCSF Breast Care Center
NOT_YET_RECRUITING

San Francisco, California, 94158, United States
Westmead Hospital
NOT_YET_RECRUITING

Westmead, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.